Details For Selected Brain Tumor Treatment
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

Back to New Treatments List Back to New Treatments List

Treatment Name: A Phase I/II Study of Anti-Angiogenesis Therapy for Atypical and/or Unresectable Meningioma
Treatment ID#: 1924         1
Age Group: Pediatric Only
Min Karnofsky Score: Not Specified
Conditions: Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Last Updated: 11/29/2014
Tumor Types: Acoustic Neuroma
Comments: Patients must have a histologically-proven diagnosis of atypical meningioma or a clinical diagnosis of an unresectable meningioma. Patients must have radiographic proof of tumor progression and/or tumor recurrence, despite conventional treatment, including surgery, radiosurgery and/or external beam radiation therapy. Patients may also have had chemotherapy.
Treatment Type: Surgery
Immunological, Biological or Targeted Therapy
Contact: Andrew B. Lassman MD
Columbia University Medical Center
Contact: Daniel Otap

New York, NY 10032 USA
  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is a combination of our internal ID and the official ID for the trial, if any.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment

Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book

Copyright (c) 1993 - 2015 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites